ArticleFrontiers in pharmacology2022

Low-Dose Anti-HIV Drug Efavirenz Mitigates Retinal Vascular Lesions in a Mouse Model of Alzheimer's Disease.

Nicole El-Darzi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.